Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002094620 | SCV002375847 | likely benign | Neurofibromatosis, type 1 | 2024-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004558847 | SCV005047583 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2016-11-02 | criteria provided, single submitter | clinical testing | The c.205-16A>G intronic alteration consists of a A to G substitution 16 nucleotides before coding exon 3 in the NF1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |